Abstract: A method of continuously producing an ethylene-vinyl acetate copolymer in a polymerization vessel containing a reaction liquid containing ethylene, vinyl acetate, a polymerization initiator and methanol, the polymerization vessel being connected via piping to a heat exchanger circulating a coolant, the method includes the steps of: supplying ethylene, the polymerization initiator and methanol to the polymerization vessel; introducing pressurized gas containing ethylene present in a gas phase portion of the polymerization vessel into the heat exchanger; supplying vinyl acetate cooled to between ?50° C. and 23° C. to an upper portion of the heat exchanger; flowing vinyl acetate down in the heat exchanger while absorbing ethylene; letting vinyl acetate dissolving ethylene out of a bottom portion of the heat exchanger and adding to the reaction liquid in the polymerization vessel; and taking the reaction liquid out of the polymerization vessel.

Abstract: Coated magnesium oxide particles having high filling efficiency and high mass-productivity and suitable for a thermal conductive filler are provided, the coated magnesium oxide particles being coated magnesium oxide particles in which the surface of magnesium oxide particles is coated with at least one of a fatty acid and a fatty acid metal salt, and wherein X in relation to particles is defined as X=[a BET specific surface area diameter calculated from a BET specific surface area of the particles]÷[D50 of the particles], provided that D50 is a particle diameter at 50% accumulation in a cumulative particle size distribution of the particles, the magnesium oxide particles having X of less than 0.2 and D50 of 5 to 100 ?m, and the coated magnesium oxide particles having X of 0.2 or more, D50 of 5 to 100 ?m, and oil absorption of less than 25 mL/100 g.

Abstract: A method of continuously producing an ethylene-vinyl acetate copolymer in a polymerization vessel containing a reaction liquid containing ethylene, vinyl acetate, a polymerization initiator and methanol, the polymerization vessel being connected via piping to a heat exchanger circulating a coolant, the method includes the steps of: supplying ethylene, the polymerization initiator and methanol to the polymerization vessel; introducing pressurized gas containing ethylene present in a gas phase portion of the polymerization vessel into the heat exchanger; supplying vinyl acetate cooled to between ?50° C. and 23° C. to an upper portion of the heat exchanger; flowing vinyl acetate down in the heat exchanger while absorbing ethylene; letting vinyl acetate dissolving ethylene out of a bottom portion of the heat exchanger and adding to the reaction liquid in the polymerization vessel; and taking the reaction liquid out of the polymerization vessel.

Abstract: A magnesium oxide powder has: a median diameter (D50) of 5 to 100 ?m; a MgO purity of 98% by mass or more; a Ca compound content of 2% by mass or less in terms of CaO; and when the magnesium oxide powder is immersed in pure water and allowed to stand at 95° C. for 24 hours, a mass ratio of calcium ions to magnesium ions, Ca/Mg, in an aqueous solution of 10 or less.

Abstract: A magnesium oxide powder has: a median diameter (D50) of 5 to 100 ?m; a MgO purity of 98% by mass or more; a Ca compound content of 2% by mass or less in terms of CaO; and when the magnesium oxide powder is immersed in pure water and allowed to stand at 95° C. for 24 hours, a mass ratio of calcium ions to magnesium ions, Ca/Mg, in an aqueous solution of 10 or less.

Abstract: Coated magnesium oxide particles having high filling efficiency and high mass-productivity and suitable for a thermal conductive filler are provided, the coated magnesium oxide particles being coated magnesium oxide particles in which the surface of magnesium oxide particles is coated with at least one of a fatty acid and a fatty acid metal salt, and wherein X in relation to particles is defined as X=[a BET specific surface area diameter calculated from a BET specific surface area of the particles]÷[D50 of the particles], provided that D50 is a particle diameter at 50% accumulation in a cumulative particle size distribution of the particles, the magnesium oxide particles having X of less than 0.2 and D50 of 5 to 100 ?m, and the coated magnesium oxide particles having X of 0.2 or more, D50 of 5 to 100 ?m, and oil absorption of less than 25 mL/100 g.

Abstract: To provide magnesium oxide which is excellent in hydration resistance and hardly causes volume expansion due to hydration and the like, a resin composition containing the same, and a method for producing the magnesium oxide powder. Magnesium oxide powder having a coating layer mainly comprising basic magnesium carbonate in the surface layer, when the amounts of substances of water vapor and carbon dioxide among the gas generated by thermal decomposition at 50 to 500° C. are respectively designated as m-H2O and m-CO2, in a heating evolved gas analysis (EGA-MS) method, the molar fraction represented by m-CO2/(m-H2O+m-CO2) being within the range of 0.3 to 0.6.

Abstract: Disclosed is a pharmaceutical composition for antifungal use, comprising: 1) one or more compounds selected from compounds represented by the general formula (1) below and physiologically acceptable salts thereof; 2) one or more compounds selected from polypropylene glycol, diesters of dibasic acids, triacetin, 2-ethyl-1,3-hexanediol, lauromacrogol, and polyoxyethylene-polyoxypropylene glycol; and 3) one or more compounds selected from glucono-?-lactone, propylene glycol, glycerin, and lactic acid. General formula (1) (In the formula, X represents a halogen or hydrogen). wherein X represents a halogen or hydrogen.

Abstract: To provide magnesium oxide which is excellent in hydration resistance and hardly causes volume expansion due to hydration and the like, a resin composition containing the same, and a method for producing the magnesium oxide powder. Magnesium oxide powder having a coating layer mainly comprising basic magnesium carbonate in the surface layer, when the amounts of substances of water vapor and carbon dioxide among the gas generated by thermal decomposition at 50 to 500° C. are respectively designated as m-H2O and m-CO2, in a heating evolved gas analysis (EGA-MS) method, the molar fraction represented by m-CO2/(m-H2O+m-CO2) being within the range of 0.3 to 0.6.

Abstract: A thermally conductive resin filler including a sintered body containing at least magnesium oxide, calcium oxide, and silicon oxide, the thermally conductive filler being characterized in that, when the molar number of calcium element contained in the total composition of the sintered body in terms of calcium oxide (CaO) is defined as MCa, and the molar number of silicon element contained in the total composition of the sintered body in terms of silicon oxide (SiO2) is defined as MSi, the molar ratio of the calcium oxide (CaO) to the silicon oxide (SiO2) represented by MCa/MSi is in the range of 0.1 or more and less than 2.0.

Abstract: Disclosed is an antifungal agent for external use, which is characterized by containing a compound represented by the general formula (1), 50 to 95 mass % of an alcohol such as ethanol, 0.1 to 35 mass % of water or the like, and 0.01 to 5 mass % of a cellulose thickening agent. X is a halogen or H.

Abstract: Disclosed is an antifungal agent for external use, which is characterized by containing a compound represented by the general formula (1), 50 to 95 mass % of an alcohol such as ethanol, 0.1 to 35 mass % of water or the like, and 0.01 to 5 mass % of a cellulose thickening agent. X is a halogen or H.

Abstract: A thermally conductive resin filler including a sintered body containing at least magnesium oxide, calcium oxide, and silicon oxide, the thermally conductive filler being characterized in that, when the molar number of calcium element contained in the total composition of the sintered body in terms of calcium oxide (CaO) is defined as MCa, and the molar number of silicon element contained in the total composition of the sintered body in terms of silicon oxide (SiO2) is defined as MSi, the molar ratio of the calcium oxide (CaO) to the silicon oxide (SiO2) represented by MCa/MSi is in the range of 0.1 or more and less than 2.0.

Abstract: Disclosed is a pharmaceutical composition for antifungal use, comprising: 1) one or more compounds selected from compounds represented by the general formula (1) below and physiologically acceptable salts thereof; 2) one or more compounds selected from polypropylene glycol, diesters of dibasic acids, triacetin, 2-ethyl-1,3-hexanediol, lauromacrogol, and polyoxyethylene-polyoxypropylene glycol; and 3) one or more compounds selected from glucono-?-lactone, propylene glycol, glycerin, and lactic acid. General formula (1) (In the formula, X represents a halogen or hydrogen). wherein X represents a halogen or hydrogen.

Abstract: Disclosed is a pharmaceutical composition for antifungal use, comprising: 1) one or more compounds selected from compounds represented by the general formula (1) below and physiologically acceptable salts thereof; 2) one or more compounds selected from polypropylene glycol, diesters of dibasic acids, triacetin, 2-ethyl-1,3-hexanediol, lauromacrogol, and polyoxyethylene-polyoxypropylene glycol; and 3) one or more compounds selected from glucono-?-lactone, propylene glycol, glycerin, and lactic acid. General formula (1) (In the formula, X represents a halogen or hydrogen). wherein X represents a halogen or hydrogen.

Abstract: Disclosed is an antifungal agent for external use, which is characterized by containing a compound represented by the general formula (1), 50 to 95 mass % of an alcohol such as ethanol, 0.1 to 35 mass % of water or the like, and 0.01 to 5 mass % of a cellulose thickening agent. X is a halogen or H.

Abstract: A breast image generating method correlates radiographing order information for instructing to radiograph each of left and right breasts of a subject in an oblique direction with identification information indicating a relationship between data of a breast image and the radiographing order information so as to be stored in a storing device. A breast is radiographed based on the radiographing order information to generate data of a breast image, radiographing order information corresponding to the generated data of a breast image is identified based on the identification information, and a stamp image is superposed at a prescribed position on the breast image taken through radiographing conducted in the oblique direction to make a composite image in accordance with whether a breast region indicated by the identified radiographing order information is left or right, so as to display the composite image on a displaying device.

Abstract: Part of a laser beam, which is generated by a laser tube and reflected by a reflection surface of a high-reflectance mirror to travel while diverging at the predetermined angle, is divided by a dividing mirror. The spectral band width of the divided laser beam is narrowed by an etalon and a diffraction grating. The laser beam with the narrowed spectral band width is reflected by a high-reflectance return mirror, returned to the laser tube, and amplified in the laser tube. The laser beam with the narrowed spectral band width is amplified in substantially the same space within the laser tube where the laser beam was generated.

Abstract: In a metal vapor laser apparatus of this invention, a cathode electrode side end portion is made longer along a tube axis than an anode electrode side end portion. A distance between a cathode side end of the discharge tube and a cathode electrode is longer along a tube axis direction than a distance between an anode side end of the discharge tube and an anode electrode.

Abstract: A metal vapor laser apparatus of this invention includes at least two high reflecting mirrors arranged one near each side end portion of a discharge tube, heating units for heating the high reflecting mirrors, and transmission windows formed to transmit a laser beam reflected by the high reflecting mirrors.